Athira pharma to present at the 39th annual j.p. morgan healthcare conference

Seattle, jan. 07, 2021 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that leen kawas, ph.d., president and chief executive officer, will present a company overview and pipeline update at the 39th annual j.p. morgan conference, being held virtually, on thursday, january 14, 2021 at 2:50 p.m. et.
ATHA Ratings Summary
ATHA Quant Ranking